LMS CALM 3.03 software delived to marketplace
August 29 2006 - 9:00AM
PR Newswire (US)
MONTREAL, Aug. 29 /PRNewswire-FirstCall/ -- LMS Medical Systems
(AMEX:LMZ; TSX:LMZ), a healthcare technology company and developer
of the CALM(TM) clinical information system and risk management
software tools for obstetrics, today announced the general
availability of a new version of its software family of products,
CALM Version 3.03. The release is currently being deployed at sites
operating on the CALM 3.0 platform. CALM 3.03 includes significant
architectural and functional enhancements to the CALM system in
line with LMS' continuing strategy of providing increased
robustness and flexibility to its customers. As a building block
for future growth, CALM 3.03 represents the architectural
foundation to support extensive interfacing capabilities which are
a prime focus of the Company. The enhancements delivered will
benefit both our clinical information system and risk management
tools. CALM Version 3.03 follows a cascade of independent releases
that have been made available to the obstetrical market over the
last year. This path is reflective of LMS' approach regarding
iterative development and tight customer feedback loops. This
allows LMS to deliver customers the desired functionality
addressing their priorities within a faster release cycle. About
LMS: LMS is a leader in the application of advanced mathematical
modeling and neural networks for medical use. The LMS CALM(TM)
Decision Support Suite provides physicians, nursing staff, risk
managers and hospital administrators with clinical information
systems and risk management tools designed to improve outcomes and
patient care for mothers and their infants during labor and
delivery. Except for historical information contained herein, the
matters discussed in this news release are forward-looking
statements. Because these forward-looking statements involve risks
and uncertainties, there are important factors that could cause
actual results to differ materially from those expressed implied by
the forward-looking statements including, but without limitation,
economic conditions in general and in the healthcare market, the
demand for and market for our products in domestic and
international markets, our current dependence on the CALM product
suite, the challenges associated with developing new products and
obtaining regulatory approvals if necessary, research and
development activities, the uncertainty of acceptance of our
products by the medical community, the lengthy sales cycle for our
products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by
others, our dependence on our distributors, physician training,
enforceability and the costs of enforcement of our patents,
potential infringements of our patents and the other factors set
forth from time to time in the Company's filings with the United
States Securities and Exchange Commission and with the Canadian
Securities Commissions. The Company has no intention of or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
DATASOURCE: LMS MEDICAL SYSTEMS INC. CONTACT: Andrea Miller,
Communications, LMS Medical Systems Inc.,(514) 488-3461 Ext. 222,
Fax: (514) 488-1880, ; http://www.lmsmedical.com/
Copyright